Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin+mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non- resectable patients)

Japanese Journal of Cancer and Chemotherapy

Volumn 23, Issue 6, 1996, Pages 707-714

  Takada, T ^a   Kato, H ^a   Matsushiro, T ^a   Nimura, Y ^a   Nagakawa, T ^a   Nakayama, T ^a   Yamauchi, H ^a   Ogata, Y ^a   Shimada, H ^a   Miyakawa, S ^a   Yamaguchi, A ^a   Sakoda, K ^a   Yasuda, H ^a   Tsukada, K ^a   Yoshida, K ^a   Ashida, H ^a   Ishikawa, Y ^a   Kotoura, Y ^a   Kinoshita, H ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Biliary tract carcinoma; FAM chemotherapy; Pancreatic carcinoma; Randomized study

Indexed keywords

DOXORUBICIN; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ALOPECIA; ARTICLE; BILE DUCT CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PANCREAS CARCINOMA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILIARY TRACT NEOPLASMS; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; JAPAN; MALE; MIDDLE AGED; MITOMYCIN; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; REMISSION INDUCTION; SURVIVAL RATE;

EID: 8944246317     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)